Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Clinical trial NCT03256344 · COMPLETED
Trial details
- NCT number
- NCT03256344
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2020-05-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.